SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-012277
Filing Date
2022-02-07
Accepted
2022-02-07 08:46:39
Documents
14
Period of Report
2022-02-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm225598d1_8k.htm   iXBRL 8-K 38509
2 EXHIBIT 3.1 tm225598d1_ex3-1.htm EX-3.1 153918
3 EXHIBIT 10.1 tm225598d1_ex10-1.htm EX-10.1 35375
  Complete submission text file 0001104659-22-012277.txt   451948

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA eyen-20220204.xsd EX-101.SCH 3042
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20220204_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20220204_pre.xml EX-101.PRE 22601
8 EXTRACTED XBRL INSTANCE DOCUMENT tm225598d1_8k_htm.xml XML 3815
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 22595611
SIC: 2834 Pharmaceutical Preparations